Skip to Content

Trainee Publications

Throughout their training, residents have many opportunities to participate in prospective protocol studies as well as to conduct retrospective clinical research. The results of such analyses are an integral part of clinical research and have frequently led to major changes in radiotherapy technique and philosophy. Our residents regularly present their research at scientific conferences such as the annual meetings of the American Society for Therapeutic Radiology and Oncology, the Radiological Society of North America and the American Radium Society. Publications resulting from their research efforts can be found in many radiation oncology and other specialty journals.

Bibliography

This bibliography represents published research manuscripts of our current trainees.

Wang J, Suri JS, Allen PK, Liao Z, Komaki R, Ho L, Hofstetter WL, Lin SH. Factors Predictive of Improved Outcomes With Multimodality Local Therapy After Palliative Chemotherapy for Stage IV Esophageal Cancer. Am J Clin Oncol, 2014; 5: 5

Tsai CJ, Wang Y, Allen PK, Mahajan A, McCutcheon IE, Rao G, Rhines LD, Tatsu CE, Armstrong TS, Maor MH, Chang EL, Brown PD, Li J. Outcomes After Surgery and Radiotherapy for Spinal Myxopapillary Ependymoma: Update of the MD Anderson Cancer Center Experience. Neurosurgery, May 12, 2014 [PMID: 24818785  DOI: 10.1227/neu.0000000000000408]

Tang C, Liao Z, Zhuang Y, Levy LB, Hung C, Li X, Krafft SP, Martel MK, Komaki R, Gomez DR. Acute phase response before treatment predicts radiation esophagitis in non-small cell lung cancer. Radiother Oncol, 2014; 20(14): 00025-00025

Tang C, Gomez DR, Wang H, Levy LB, Zhuang Y, Xu T, Nguyen Q, Komaki R, Liao Z. Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer. Int J Radiat Oncol Biol Phys, 2014; 88(2): 319-325

Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy, 2014; 13(1): 68-74

Takiar V, Akay CL, Stauder MC, Tereffe W, Alvarez RH, Hoffman KE, Perkins GH, Strom EA, Buchholz TA, Ueno NT, Babiera G, Woodward WA. Predictors of durable no evidence of disease status in de novo metastatic inflammatory breast cancer patients treated with neoadjuvant chemotherapy and post-mastectomy radiation. Springerplus, 2014; 3(166): 2193-1801

Smith GL, Jiang J, Buchholz TA, Xu Y, Hoffman KE, Giordano SH, Hunt KK, Smith BD. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys, 2014; 88(2): 274-284

Mahmood U, Pugh T, Frank S, Levy L, Walker G, Haque W, Koshy M, Graber W, Swanson D, Hoffman K, Kuban D, Lee A. Declining use of brachytherapy for the treatment of prostate cancer. Brachytherapy, 2014; 13(2): 157-162

Lacerda L, Reddy JP, Liu D, Larson R, Li L, Masuda H, Brewer T, Debeb BG, Xu W, Hortobagyi GN, Buchholz TA, Ueno NT, Woodward WA. Simvastatin Radiosensitizes Differentiated and Stem-Like Breast Cancer Cell Lines and Is Associated With Improved Local Control in Inflammatory Breast Cancer Patients Treated With Postmastectomy Radiation. Stem Cells Transl Med, 2014; 15: 2013-0204

Koay EJ, Truty MJ, Cristini V, Thomas RM, Chen R, Chatterjee D, Kang Y, Bhosale PR, Tamm EP, Crane CH, Javle M, Katz MH, Gottumukkala VN, Rozner MA, Shen H, Lee JE, Wang H, Chen Y, Plunkett W, Abbruzzese JL, Wolff RA, Varadhachary GR, Ferrari M, Fleming JB. Transport properties of pancreatic cancer describe gemcitabine delivery and response. J Clin Invest, 2014; 10(73455)

Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Jr., Fuller CD. Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med, 2014; 89(5): 767-773

Holliday EB, Jagsi R, Thomas CR, Jr., Wilson LD, Fuller CD. Standing on the shoulders of giants: results from the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP). Int J Radiat Oncol Biol Phys, 2014; 88(1): 18-24

Hoffman KE, Voong KR, Pugh TJ, Skinner H, Levy LB, Takiar V, Choi S, Du W, Frank SJ, Johnson J, Kanke J, Kudchadker RJ, Lee AK, Mahmood U, McGuire SE, Kuban DA. Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial. Int J Radiat Oncol Biol Phys, 2014; 88(5): 1074-1084

Choi M, Holliday EB, Jagsi R, Wilson LD, Fuller CD, Thomas CR, Jr. Citation-based Estimation of Scholarly Activity Among Domestic Academic Radiation Oncologists: Five-Year Update. J Radiat Oncol, 2014; 3(1): 115-122
Barney CL, Brown AP, Grosshans DR, McAleer MF, de Groot JF, Puduvalli V, Tucker SL, Crawford CN, Gilbert MR, Brown PD, Mahajan A. Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. Neuro Oncol, 2014; 16(2): 303-309

Ahmed AA, Egleston B, Holliday E, Eastwick G, Takita C, Jagsi R. Gender trends in radiation oncology in the United States: a 30-year analysis. Int J Radiat Oncol Biol Phys, 2014; 88(1): 33-38

Weksberg DC, Allen PK, Hoffman KE, Litton JK, Strom EA, Shah RR, Kuerer HM, Hunt KK, Buchholz TA, Mittendorf EA. Outcomes and predictive factors for salvage therapy after local-regional recurrence following neoadjuvant chemotherapy and breast conserving therapy. Ann Surg Oncol, Oct, 2013; 20(11): 3430-3437 [PMID: 23720073  DOI: 10.1245/s10434-013-3032-4]

Wang J, Wei C, Tucker SL, Myles B, Palmer M, Hofstetter WL, Swisher SG, Ajani JA, Cox JD, Komaki R, Liao Z, Lin SH. Predictors of postoperative complications after trimodality therapy for esophageal cancer. Int J Radiat Oncol Biol Phys, Aug 1, 2013; 86(5): 885-891 [PMID: 23845841  DOI: 10.1016/j.ijrobp.2013.04.006 S0360-3016(13)00396-9 [pii]]

Wang J, Myles B, Wei C, Chang JY, Hofstetter WL, Ajani JA, Swisher SG, Cox JD, Komaki R, Liao Z, Lin SH. Obesity and outcomes in patients treated with chemoradiotherapy for esophageal carcinoma. Dis Esophagus, Apr 26, 2013 [PMID: 23621168 PMCID: 3740061 DOI: 10.1111/dote.12074]

Walker GV, Giordano SH, Williams M, Jiang J, Niu J, MacKinnon J, Anderson P, Wohler B, Sinclair AH, Boscoe FP, Schymura MJ, Buchholz TA, Smith BD. Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries. Int J Radiat Oncol Biol Phys, Jul 15, 2013; 86(4): 686-693 [PMID: 23773392  DOI: 10.1016/j.ijrobp.2013.03.016 S0360-3016(13)00327-1 [pii]]

Walker GV, Gilbert MR, Prabhu SS, Brown PD, McAleer MF. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice. J Neurooncol, Mar, 2013; 112(1): 83-89 [PMID: 23266723  DOI: 10.1007/s11060-012-1029-7]

Tsai CJ, Sulman EP, Eifel PJ, Jhingran A, Allen PK, Deavers MT, Klopp AH. Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix. Gynecol Oncol, Apr 30, 2013 [PMID: 23643871  DOI: S0090-8258(13)00312-0 [pii]  10.1016/j.ygyno.2013.04.056]

Tsai CJ, Li J, Gonzalez-Angulo AM, Allen PK, Woodward WA, Ueno NT, Lucci A, Krishnamurthy S, Gong Y, Yang W, Cristofanilli M, Valero V, Buchholz TA. Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy. Am J Clin Oncol, May 2, 2013 [PMID: 23648437  DOI: 10.1097/COC.0b013e3182937921]

Tsai CJ, Hofstede TM, Sturgis EM, Garden AS, Lindberg ME, Wei QY, Tucker SL, Dong L. Osteoradionecrosis and Radiation Dose to the Mandible in Patients With Oropharyngeal Cancer. Int J Radiat Oncol, Feb 1, 2013; 85(2): 415-420 [PMID: ISI:000313642000030  DOI: DOI 10.1016/j.ijrobp.2012.05.032]

Takiar V, Strom EA, Baumann DP, Meric-Bernstam F, Alvarez RH, Gonzalez-Angulo AM. Locoregional Interaction of Ixabepilone (Ixempra) After Breast Cancer Radiation. Oncologist, Mar, 2013; 18(3): 265-270 [PMID: ISI:000316783300006  DOI: DOI 10.1634/theoncologist.2012-0348]

Takiar V, Pugh TJ, Swanson D, Kudchadker RJ, Bruno TL, McAvoy S, Mahmood U, Frank SJ. MRI-based sector analysis enhances prostate palladium-103 brachytherapy quality assurance in a phase II prospective trial of men with intermediate-risk localized prostate cancer. Brachytherapy, May 11, 2013 [PMID: 23669149  DOI: S1538-4721(13)00244-4 [pii] 10.1016/j.brachy.2013.04.001]

Takiar V, Fontanilla HP, Eifel PJ, Jhingran A, Kelly P, Iyer RB, Levenback CF, Zhang Y, Dong L, Klopp A. Anatomic distribution of fluorodeoxyglucose-avid para-aortic lymph nodes in patients with cervical cancer. Int J Radiat Oncol Biol Phys, Mar 15, 2013; 85(4): 1045-1050 [PMID: 23332221  DOI: 10.1016/j.ijrobp.2012.11.032 S0360-3016(12)03830-8 [pii]]

Shirvani SM, Juloori A, Allen PK, Komaki R, Liao Z, Gomez D, O'Reilly M, Welsh J, Papadimitrakopoulou V, Cox JD, Chang JY. Comparison of 2 common radiation therapy techniques for definitive treatment of small cell lung cancer. Int J Radiat Oncol Biol Phys, Sep 1, 2013; 87(1): 139-147 [PMID: 23920393  DOI: 10.1016/j.ijrobp.2013.05.040 S0360-3016(13)00633-0 [pii]]

Shirvani SM, Jiang J, Gomez DR, Chang JY, Buchholz TA, Smith BD. Intensity modulated radiotherapy for stage III non-small cell lung cancer in the United States: Predictors of use and association with toxicities. Lung Cancer, Aug 21, 2013 [PMID: 24018022  DOI: S0169-5002(13)00380-2 [pii] 10.1016/j.lungcan.2013.08.015]

Shirvani SM, Chang JY, Roth JA. Can stereotactic ablative radiotherapy in early stage lung cancers produce comparable success as surgery? Thorac Surg Clin, Aug, 2013; 23(3): 369-381 [PMID: 23931020  DOI: 10.1016/j.thorsurg.2013.05.009 S1547-4127(13)00075-3 [pii]]

Sahgal A, Atenafu EG, Chao S, Al-Omair A, Boehling N, Balagamwala EH, Cunha M, Thibault I, Angelov L, Brown P, Suh J, Rhines LD, Fehlings MG, Chang E. Vertebral compression fracture after spine stereotactic body radiotherapy: a multi-institutional analysis with a focus on radiation dose and the spinal instability neoplastic score. J Clin Oncol, Sep 20, 2013; 31(27): 3426-3431 [PMID: 23960179  DOI: 10.1200/JCO.2013.50.1411 JCO.2013.50.1411 [pii]]

Rana S, Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Jr., Fuller CD. Scholastic activity among radiation oncology residents at US academic institutions: a benchmark analysis. J Cancer Educ, 2013; 28(3): 541-546

McAvoy SA, Ciura KT, Rineer JM, Allen PK, Liao Z, Chang JY, Palmer MB, Cox JD, Komaki R, Gomez DR. Feasibility of proton beam therapy for reirradiation of locoregionally recurrent non-small cell lung cancer. Radiother Oncol, Sep 6, 2013 [PMID: 24016675  DOI: S0167-8140(13)00400-3 [pii] 10.1016/j.radonc.2013.08.014]

Kim MM, Allen P, Gonzalez-Angulo AM, Woodward WA, Meric-Bernstam F, Buzdar AU, Hunt KK, Kuerer HM, Litton JK, Hortobagyi GN, Buchholz TA, Mittendorf EA. Pathologic complete response to neoadjuvant chemotherapy with trastuzumab predicts for improved survival in women with HER2-overexpressing breast cancer. Ann Oncol, Aug, 2013; 24(8): 1999-2004 [PMID: 23562929 PMCID: 3718505 DOI: 10.1093/annonc/mdt131 mdt131 [pii]]

Holliday EB, Sulman EP. Tumor Prognostic Factors and the Challenge of Developing Predictive Factors. Current Oncology Reports, Feb, 2013; 15(1): 33-46 [PMID: ISI:000313345400008  DOI: DOI 10.1007/s11912-012-0283-3]

Holliday E, Fuller CD, Wilson LD, Thomas CR, Jr. Success breeds success: authorship distribution in the Red Journal, 1975-2011. Int J Radiat Oncol Biol Phys, 2013; 85(1): 23-28

Gomez DR, Gillin M, Liao Z, Wei C, Lin SH, Swanick C, Alvarado T, Komaki R, Cox JD, Chang JY. Phase 1 study of dose escalation in hypofractionated proton beam therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys, Jul 15, 2013; 86(4): 665-670 [PMID: 23688815  DOI: 10.1016/j.ijrobp.2013.03.035 S0360-3016(13)00359-3 [pii]]

Fontanilla HP, Klopp AH, Lindberg ME, Jhingran A, Kelly P, Takiar V, Iyer RB, Levenback CF, Zhang Y, Dong L, Eifel PJ. Anatomic distribution of [(18)F] fluorodeoxyglucose-avid lymph nodes in patients with cervical cancer. Pract Radiat Oncol, 2013; 3(1): 45-53

Evans JD, Gomez DR, Amini A, Rebueno N, Allen PK, Martel MK, Rineer JM, Ang KK, McAvoy S, Cox JD, Komaki R, Welsh JW. Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol, Mar, 2013; 106(3): 327-332 [PMID: 23453540  DOI: 10.1016/j.radonc.2013.02.002 S0167-8140(13)00049-2 [pii]]

Christensen EN, Yu HZ, Klopp AH, Tsai JC, Lawyer AA, Court LE, Eifel PJ. Variable impact of intracavitary brachytherapy fractionation schedule on biologically effective dose to organs at risk in patients with cervical cancer. Brachytherapy, 2013; 1(13): 00355-00353

Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era? Int J Radiat Oncol Biol Phys, Mar 1, 2013; 85(3): 693-699 [PMID: 22836052  DOI: 10.1016/j.ijrobp.2012.06.030 S0360-3016(12)00856-5 [pii]]

Castle KO, Guadagnolo BA, Tsai CJ, Feig BW, Zagars GK. Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys, Jul 1, 2013; 86(3): 585-590 [PMID: 23628134  DOI: 10.1016/j.ijrobp.2013.02.024 S0360-3016(13)00216-2 [pii]]

Brown AP, Pugh TJ, Swanson DA, Kudchadker RJ, Bruno TL, Christensen EN, van Vulpen M, Frank SJ. Improving prostate brachytherapy quality assurance with MRI-CT fusion-based sector analysis in a phase II prospective trial of men with intermediate-risk prostate cancer. Brachytherapy, Sep-Oct, 2013; 12(5): 401-407 [PMID: 23380383  DOI: 10.1016/j.brachy.2012.10.001 S1538-4721(13)00015-9 [pii]]

Brown AP, Jhingran A, Klopp AH, Schmeler KM, Ramirez PT, Eifel PJ. Involved-field radiation therapy for locoregionally recurrent ovarian cancer. Gynecol Oncol, Aug, 2013; 130(2): 300-305 [PMID: 23648467  DOI: 10.1016/j.ygyno.2013.04.469 S0090-8258(13)00725-7 [pii]]

Brown AP, Gaffney DK, Dodson MK, Soisson AP, Belnap TW, Alleman K, Sause WT. Survival analysis of endometrial cancer patients with positive lymph nodes. Int J Gynecol Cancer, Jun, 2013; 23(5): 861-868 [PMID: 23598890  DOI: 10.1097/IGC.0b013e3182915c3e]

Brown AP, Barney CL, Grosshans DR, McAleer MF, de Groot JF, Puduvalli VK, Tucker SL, Crawford CN, Khan M, Khatua S, Gilbert MR, Brown PD, Mahajan A. Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults With Medulloblastoma. Int J Radiat Oncol, Jun 1, 2013; 86(2): 277-284 [PMID: ISI:000319500200018  DOI: DOI 10.1016/j.ijrobp.2013.01.014]

Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday E, Jones WE, 3rd, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD. Prospective Assessment of an Atlas-Based Intervention Combined With Real-Time Software Feedback in Contouring Lymph Node Levels and Organs-at-Risk in the Head and Neck: Quantitative Assessment of Conformance to Expert Delineation. Pract Radiat Oncol, Jul 1, 2013; 3(3): 186193 [PMID: 23853674 PMCID: 3706296 DOI: 10.1016/j.prro.2012.11.002]

Albert JM, Swanson DA, Pugh TJ, Zhang M, Bruno TL, Kudchadker RJ, Frank SJ. Magnetic resonance imaging-based treatment planning for prostate brachytherapy. Brachytherapy, Jan-Feb, 2013; 12(1): 30-37 [PMID: ISI:000313759300006  DOI: DOI 10.1016/j.brachy.2012.03.009]

Albert JM. Radiation risk from CT: implications for cancer screening. AJR Am J Roentgenol, Jul, 2013; 201(1): W81-87 [PMID: 23789701  DOI: 10.2214/AJR.12.9226]

Welsh J, Palmer MB, Ajani JA, Liao ZX, Swisher SG, Hofstetter WL, Allen PK, Settle SH, Gomez D, Likhacheva A, Cox JD, Komaki R. Esophageal Cancer Dose Escalation Using a Simultaneous Integrated Boost Technique. Int J Radiat Oncol, Jan, 2012; 82(1): 468-474 [PMID: ISI:000298526100067  DOI: DOI 10.1016/j.ijrobp.2010.10.023]

Weksberg DC, Shibamoto Y, Paulino AC. Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. Int J Radiat Oncol Biol Phys, 2012; 82(4): 1341-1351

Weksberg DC, Palmer MB, Vu KN, Rebueno NC, Sharp HJ, Luo D, Yang JN, Shiu AS, Rhines LD, McAleer MF, Brown PD, Chang EL. Generalizable class solutions for treatment planning of spinal stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys, Nov 1, 2012; 84(3): 847-853 [PMID: 22445000  DOI: 10.1016/j.ijrobp.2011.12.060 S0360-3016(11)03764-3 [pii]]

Weksberg DC, Bilton SD, Chang EL. Use of a deformable atlas to identify cryptic critical structures in the treatment of glioblastoma multiforme. PLoS One, 2012; 7(3): e32098 [PMID: 22461883 PMCID: 3312881 DOI: 10.1371/journal.pone.0032098 PONE-D-11-21958 [pii]]

Wang XS, Rhines LD, Shiu AS, Yang JN, Selek U, Gning I, Liu P, Allen PK, Azeem SS, Brown PD, Sharp HJ, Weksberg DC, Cleeland CS, Chang EL. Stereotactic body radiation therapy for management of spinal metastases in patients without spinal cord compression: a phase 1-2 trial. Lancet Oncol, Apr, 2012; 13(4): 395-402 [PMID: 22285199 PMCID: 3605896 DOI: 10.1016/S1470-2045(11)70384-9 S1470-2045(11)70384-9 [pii]]

Wang J, Lin SH, Dong L, Balter P, Mohan R, Komaki R, Cox JD, Starkschall G. Quantifying the interfractional displacement of the gastroesophageal junction during radiation therapy for esophageal cancer. Int J Radiat Oncol Biol Phys, 2012; 83(2): 21

Walker GV, Niikura N, Yang W, Rohren E, Valero V, Woodward WA, Alvarez RH, Lucci A, Jr., Ueno NT, Buchholz TA. Pretreatment staging positron emission tomography/computed tomography in patients with inflammatory breast cancer influences radiation treatment field designs. Int J Radiat Oncol Biol Phys, Aug 1, 2012; 83(5): 1381-1386 [PMID: 22284689  DOI: 10.1016/j.ijrobp.2011.10.040 S0360-3016(11)03447-X [pii]]

Walker GV, Li J, Mahajan A, McAleer MF, de Groot JF, Azeem SS, Brown PD. Decreasing radiation therapy utilization in adult patients with glioblastoma multiforme: a population-based analysis. Cancer, Sep 15, 2012; 118(18): 4538-4544 [PMID: 22359097  DOI: 10.1002/cncr.27439]

Smith GL, Xu Y, Buchholz TA, Giordano SH, Jiang J, Shih YC, Smith BD. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA, May 2, 2012; 307(17): 1827-1837 [PMID: 22550197 PMCID: 3397792 DOI: 10.1001/jama.2012.3481 307/17/1827 [pii]]

Smith BD, Smith GL, Buchholz TA. Brachytherapy vs whole-breast irradiation: Trial by data. Int J Radiat Oncol, 2012; 83(4): 1078-1080

Shirvani SM, Komaki R, Heymach JV, Fossella FV, Chang JY. Positron emission tomography/computed tomography-guided intensity-modulated radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys, Jan 1, 2012; 82(1): e91-97 [PMID: 21489716 PMCID: 3465842 DOI: 10.1016/j.ijrobp.2010.12.072 S0360-3016(11)00221-5 [pii]]

Shirvani SM, Jiang J, Chang JY, Welsh JW, Gomez DR, Swisher S, Buchholz TA, Smith BD. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys, Dec 1, 2012; 84(5): 1060-1070 [PMID: 22975611 PMCID: 3776428 DOI: 10.1016/j.ijrobp.2012.07.2354 S0360-3016(12)03298-1 [pii]]

Likhacheva A, Pinnix CC, Parikh N, Allen PK, Guha-Thakurta N, McAleer M, Sulman EP, Mahajan A, Shiu A, Luo D, Chiu M, Brown PD, Prabhu SS, Chang EL. Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone. J Neurosurg, Dec, 2012; 117 Suppl: 38-44 [PMID: 23205787  DOI: 10.3171/2012.3.GKS1289]

Koay EJ, Teh BS, Paulino AC, Butler EB. Treatment trends and outcomes of small-cell carcinoma of the bladder. Int J Radiat Oncol, 2012; 83(1): 64-70

Koay EJ, Lege D, Mohan R, Komaki R, Cox JD, Chang JY. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer. Int J Radiat Oncol Biol Phys, Dec 1, 2012; 84(5): 1093-1100 [PMID: 22543217 PMCID: 3409930 DOI: 10.1016/j.ijrobp.2012.02.041 S0360-3016(12)00307-0 [pii]]

Koay E, Sulman EP. Management of brain metastasis: past lessons, modern management, and future considerations. Curr Oncol Rep, Feb, 2012; 14(1): 70-78 [PMID: 22071681  DOI: 10.1007/s11912-011-0205-9]

Kim MM, Kudchadker RJ, Kanke JE, Zhang S, Perkins GH. Bolus electron conformal therapy for the treatment of recurrent inflammatory breast cancer: a case report. Med Dosim, Summer, 2012; 37(2): 208-213 [PMID: 21978532  DOI: 10.1016/j.meddos.2011.07.004 S0958-3947(11)00156-7 [pii]]

Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in Prostate Cancer Survival Over Time A 20-Year Analysis. Cancer Journal, Jan-Feb, 2012; 18(1): 1-8 [PMID: ISI:000300304600001  DOI: Doi 10.1097/Ppo.0b013e3182467419]

Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: Who dies of disease? European Journal of Cancer, Jul, 2012; 48(11): 1664-1671 [PMID: ISI:000305781300010  DOI: DOI 10.1016/j.ejca.2012.01.026]

Kim MM, Dawood S, Allen P, Sahin AA, Woodward WA, Smith BD, Strom EA, Hunt KK, Meric-Bernstam F, Gonzalez-Angulo AM, Buchholz TA. Hormone Receptor Status Influences the Locoregional Benefit of Trastuzumab in Patients With Nonmetastatic Breast Cancer. Cancer, Oct 15, 2012; 118(20): 4936-4943 [PMID: ISI:000310082500006  DOI: Doi 10.1002/Cncr.27502]

Grosshans D, Boehling NS, Palmer M, Spicer C, Erice R, Cox JD, Komaki R, Chang JY. Improving cardiac dosimetry: Alternative beam arrangements for intensity modulated radiation therapy planning in patients with carcinoma of the distal esophagus. Pract Radiat Oncol, 2012; 2(1): 41-45

Grant JD, Stevens SM, Woller SC, Lee EW, Kee ST, Liu DM, Lohan DG, Elliott CG. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost, Dec, 2012; 108(6): 1097-1108 [PMID: 23093319  DOI: 10.1160/TH12-05-0352 12-05-0352 [pii]]

Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, Sahoo N, Meyer JJ, Mahajan A, Woo SY. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys, Feb 1, 2012; 82(2): 643-652 [PMID: 21277111  DOI: 10.1016/j.ijrobp.2010.11.027 S0360-3016(10)03635-7 [pii]]

Boehling NS, Grosshans DR, Allen PK, McAleer MF, Burton AW, Azeem S, Rhines LD, Chang EL. Vertebral compression fracture risk after stereotactic body radiotherapy for spinal metastases. J Neurosurg Spine, Apr, 2012; 16(4): 379-386 [PMID: 22225488  DOI: 10.3171/2011.11.SPINE116]

Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol, Sep, 2012; 23(9): 2346-2352 [PMID: 22357249  DOI: 10.1093/annonc/mds001 mds001 [pii]]

Welsh J, Gomez D, Palmer MB, Riley BA, Mayankkumar AV, Komaki R, Dong L, Zhu XR, Likhacheva A, Liao Z, Hofstetter WL, Ajani JA, Cox JD. Intensity-modulated proton therapy further reduces normal tissue exposure during definitive therapy for locally advanced distal esophageal tumors: a dosimetric study. Int J Radiat Oncol Biol Phys, Dec 1, 2011; 81(5): 1336-1342 [PMID: 21470796  DOI: 10.1016/j.ijrobp.2010.07.2001 S0360-3016(10)03122-6 [pii]]

Welsh J, Amini A, Likhacheva A, Erasmus JJ, Gomez D, Davila M, Mehran RJ, Komaki R, Liao Z, Hofstetter WL, Lee HJ, Bhutani MS, Ajani JA. Update: modern approaches to the treatment of localized esophageal cancer. Curr Oncol Rep, Jun, 2011; 13(3): 157-167 [PMID: 21365188  DOI: 10.1007/s11912-011-0158-z]

Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord CB, Walker GV, Fuller CD, Kim JS, Thomas CR, Jr. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol, 2011; 29(35): 4627-4632

Walker GV, Ahmed S, Allen P, Gidley PW, Woo SY, DeMonte F, Chang EL, Mahajan A. Radiation-induced middle ear and mastoid opacification in skull base tumors treated with radiotherapy. Int J Radiat Oncol Biol Phys, Dec 1, 2011; 81(5): e819-823 [PMID: 21277110  DOI: 10.1016/j.ijrobp.2010.11.047 S0360-3016(10)03670-9 [pii]]

Tsai CJ, Das P. Impact of PET/CT-based radiation therapy planning in gastrointestinal malignancies. PET Clinics, 2011; 6(2): 185-193

Tsai CJ, Crane CH, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Feig BW, Eng C, Krishnan S, Maru DM, Das P. Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for rectal adenocarcinoma. Cancer, Aug 15, 2011; 117(16): 3713-3722 [PMID: 21328329 PMCID: 3266661 DOI: 10.1002/cncr.25973]

Smith GL, Xu Y, Buchholz TA, Smith BD, Giordano SH, Haffty BG, Vicini FA, White JR, Arthur DW, Harris JR, Shih YC. Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol, Jan 10, 2011; 29(2): 157-165 [PMID: 21135274  DOI: 10.1200/JCO.2009.27.0942 JCO.2009.27.0942 [pii]]

Smith BD, Pan IW, Shih YC, Smith GL, Harris JR, Punglia R, Pierce LJ, Jagsi R, Hayman JA, Giordano SH, Buchholz TA. Adoption of intensity-modulated radiation therapy for breast cancer in the United States. J Natl Cancer Inst, May 18, 2011; 103(10): 798-809 [PMID: 21525437  DOI: 10.1093/jnci/djr100 djr100 [pii]]

Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, Buchholz TA. Improvement in breast cancer outcomes over time: are older women missing out? J Clin Oncol, Dec 10, 2011; 29(35): 4647-4653 [PMID: 22067407  DOI: 10.1200/JCO.2011.35.8408 JCO.2011.35.8408 [pii]]

Shirvani SM, Pan IW, Buchholz TA, Shih YC, Hoffman KE, Giordano SH, Smith BD. Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women. Cancer, Oct 15, 2011; 117(20): 4595-4605 [PMID: 21710653  DOI: 10.1002/cncr.26081]

Shirvani SM, Kudchadker RJ, Bruno TL, Likhacheva A, Swanson DA, Frank SJ. Impact of urinary catheterization on dosimetry after prostate implant brachytherapy with palladium-103 or iodine-125. Brachytherapy, Jul-Aug, 2011; 10(4): 269-274 [PMID: 21296031  DOI: 10.1016/j.brachy.2010.12.001 S1538-4721(10)00355-7 [pii]]

Shih YC, Chien CR, Xu Y, Pan IW, Smith GL, Buchholz TA. Economic burden of renal cell carcinoma: Part I--an updated review. Pharmacoeconomics, Apr, 2011; 29(4): 315-329 [PMID: 21395351  DOI: 10.2165/11586100-000000000-00000 4 [pii]]

Likhacheva A, Rosenthal DI, Hanna E, Kupferman M, Demonte F, El-Naggar AK. Sinonasal neuroendocrine carcinoma: impact of differentiation status on response and outcome. Head Neck Oncol, 2011; 3: 32 [PMID: 21794118 PMCID: 3154852 DOI: 10.1186/1758-3284-3-32 1758-3284-3-32 [pii]]

Koay EJ, Teh BS, Paulino AC, Butler EB. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. Cancer, 2011; 117(23): 5325-5333

Albert JM, Gonzalez-Angulo AM, Guray M, Sahin A, Tereffe W, Woodward WA, Strom EA, Hunt KK, Tucker SL, Buchholz TA. Patients With Only 1 Positive Hormone Receptor Have Increased Locoregional Recurrence Compared With Patients With Estrogen Receptor-Positive Progesterone Receptor-Positive Disease in Very Early Stage Breast Cancer. Cancer, Apr 15, 2011; 117(8): 1595-1601 [PMID: ISI:000289213300007  DOI: Doi 10.1002/Cncr.25694]

Albert JM, Buzdar AU, Guzman R, Allen PK, Strom EA, Perkins GH, Woodward WA, Hoffman KE, Tereffe W, Hunt KK, Buchholz TA, Oh JL. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control. Breast Cancer Res Tr, Jul, 2011; 128(2): 421-427 [PMID: ISI:000291866300012  DOI: DOI 10.1007/s10549-011-1562-7]

Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer, Sep 1, 2010; 116(17): 4000-4006 [PMID: 20564117  DOI: 10.1002/cncr.25197]

Smith GL, Shih YCT, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Racial Disparities in the Use of Radiotherapy After Breast-Conserving Surgery A National Medicare Study. Cancer, Feb 1, 2010; 116(3): 734-741 [PMID: ISI:000274169200021  DOI: Doi 10.1002/Cncr.24741]

Smith GL, Shih YC, Giordano SH, Smith BD, Buchholz TA. A method to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov, 2010; 7: 1 [PMID: 20145734 PMCID: 2818641 DOI: 10.1186/1742-5573-7-1]

Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA. The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol, Dec 10, 2010; 28(35): 5160-5165 [PMID: 20956628  DOI: 10.1200/JCO.2010.31.2520 JCO.2010.31.2520 [pii]]

McAvoy S, Baker KS, Mulrooney D, Blaes A, Arora M, Burns LJ, Majhail NS. Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation. Biol Blood Marrow Transplant, 2010; 16(9): 1231-1236

Smith GL, Xu Y, Shih YCT, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-Conserving Surgery in Older Patients with Invasive Breast Cancer: Current Patterns of Treatment Across the United States. J Am Coll Surgeons, 2009; 209(4): 425-433.e422

Smith GL, Smith BD, Garden AS, Rosenthal DI, Sherman SI, Morrison WH, Schwartz DL, Weber RS, Buchholz TA. Hypothyroidism in older patients with head and neck cancer after treatment with radiation: A population-based study. Head and Neck, 2009; 31(8): 1031-1038

Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of Care and Locoregional Treatment Outcomes in Older Esophageal Cancer Patients: The SEER-Medicare Cohort. Int J Radiat Oncol, 2009; 74(2): 482-489

Smith BD, Smith GL, Roberts KB, Buchholz TA. Baseline Utilization of Breast Radiotherapy Before Institution of the Medicare Practice Quality Reporting Initiative. Int J Radiat Oncol, 2009; 74(5): 1506-1512

Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. Future of cancer incidence in the United States: Burdens upon an aging, changing nation. Journal of Clinical Oncology, 2009; 27(17): 2758-2765


© 2014 The University of Texas MD Anderson Cancer Center